CN Patent

CN101068538A — 加巴喷丁前体药物持续释放口服剂型

Assigned to XenoPort Inc · Expires 2007-11-07 · 19y expired

What this patent protects

公开了加巴喷丁前体药物1－{[(α－异丁酰氧基乙氧基)羰基]氨甲基}－1－环己烷乙酸的持续释放口服剂型。这些剂型可用于治疗或预防加巴喷丁在治疗上对其有效的疾病和障碍。

USPTO Abstract

公开了加巴喷丁前体药物1－{[(α－异丁酰氧基乙氧基)羰基]氨甲基}－1－环己烷乙酸的持续释放口服剂型。这些剂型可用于治疗或预防加巴喷丁在治疗上对其有效的疾病和障碍。

Drugs covered by this patent

Patent Metadata

Patent number
CN101068538A
Jurisdiction
CN
Classification
—
Expires
2007-11-07
Drug substance claim
No
Drug product claim
No
Assignee
XenoPort Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.